IT1245890B - Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. - Google Patents

Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.

Info

Publication number
IT1245890B
IT1245890B ITBO910113A ITBO910113A IT1245890B IT 1245890 B IT1245890 B IT 1245890B IT BO910113 A ITBO910113 A IT BO910113A IT BO910113 A ITBO910113 A IT BO910113A IT 1245890 B IT1245890 B IT 1245890B
Authority
IT
Italy
Prior art keywords
gastro
resistant
bile acids
tablets
pharmaceutical formulations
Prior art date
Application number
ITBO910113A
Other languages
English (en)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ITBO910113A0 publication Critical patent/ITBO910113A0/it
Priority to ITBO910113A priority Critical patent/IT1245890B/it
Priority to US07/861,466 priority patent/US5380533A/en
Priority to DE69212879T priority patent/DE69212879T2/de
Priority to ES92105716T priority patent/ES2090395T3/es
Priority to EP92105716A priority patent/EP0509335B1/en
Priority to CA002065773A priority patent/CA2065773C/en
Priority to JP4091130A priority patent/JP2509045B2/ja
Priority to KR1019920006052A priority patent/KR970005176B1/ko
Publication of ITBO910113A1 publication Critical patent/ITBO910113A1/it
Application granted granted Critical
Publication of IT1245890B publication Critical patent/IT1245890B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulazioni farmaceutiche per uso orale ricoperte da una pellicola gastroresistente enterosolubile, preferibilmente scelte tra granulati gastroresistenti, compresse gastroresistenti, capsule gastroresistenti, di gelatina dura contenenti polveri o granulati o due o più compresse o sospensioni oleose, capsule gastroresistenti di gelatina molle contenenti sospensioni oleose e capsule di gelatina dura contenenti granulati gastroresistenti o due o più compresse gastroresistenti, contenenti quantità terapeuticamente efficaci di acidi biliari in miscela con sostanze aventi carattere basico fisiologicamente compatibili che favoriscono la salificazione e quindi l'assorbimento degli acidi biliari nel tratto intestinale, processo per la loro preparazione e loro uso terapeutico nel trattamento delle calcolosi biliari, delle dispepsie biliari, della cirrosi biliare e delle epatopatie croniche e colestatiche.
ITBO910113A 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. IT1245890B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITBO910113A IT1245890B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
US07/861,466 US5380533A (en) 1991-04-12 1992-04-01 Gastroresistant pharmaceutical formulations for oral administration containing bile acids
EP92105716A EP0509335B1 (en) 1991-04-12 1992-04-02 Gastroresistant pharmaceutical formulations for oral administration containing bile acids
ES92105716T ES2090395T3 (es) 1991-04-12 1992-04-02 Formulados farmaceuticos gastroresistentes para administracion por via oral que contienen acidos biliares.
DE69212879T DE69212879T2 (de) 1991-04-12 1992-04-02 Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
CA002065773A CA2065773C (en) 1991-04-12 1992-04-10 Gastroresistant pharmaceutical formulations for oral administration containing bile acids
JP4091130A JP2509045B2 (ja) 1991-04-12 1992-04-10 胆汁酸を含有する経口投与用の胃液耐性のある製剤
KR1019920006052A KR970005176B1 (ko) 1991-04-12 1992-04-11 담즙산을 함유하는 경구용 위내성 의약 포뮬레이션

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910113A IT1245890B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.

Publications (3)

Publication Number Publication Date
ITBO910113A0 ITBO910113A0 (it) 1991-04-12
ITBO910113A1 ITBO910113A1 (it) 1992-10-12
IT1245890B true IT1245890B (it) 1994-10-25

Family

ID=11337390

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO910113A IT1245890B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.

Country Status (8)

Country Link
US (1) US5380533A (it)
EP (1) EP0509335B1 (it)
JP (1) JP2509045B2 (it)
KR (1) KR970005176B1 (it)
CA (1) CA2065773C (it)
DE (1) DE69212879T2 (it)
ES (1) ES2090395T3 (it)
IT (1) IT1245890B (it)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
KR100578669B1 (ko) * 1997-05-29 2006-12-07 동아제약주식회사 우르소데옥시콜린산을함유하는투명연질캅셀
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
RU2224523C2 (ru) 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
DE19906290A1 (de) * 1999-02-15 2000-08-17 Falk Pharma Gmbh Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
CN100558407C (zh) * 2000-02-04 2009-11-11 柳署弘 制备含有胆汁酸的澄清水溶液剂型
AR028023A1 (es) * 2000-04-19 2003-04-23 Borody Thomas J Una composicion farmaceutica para el tratamiento de la hiperlipidemia y el uso de dicha composicion para la preparacion de medicamentos
US7166234B1 (en) * 2000-10-26 2007-01-23 Integrated Biomedical Technology, Inc. Dialdehyde assay
KR100368936B1 (ko) * 2000-10-04 2003-01-24 주식회사 대웅 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제
SK287902B6 (sk) * 2001-01-31 2012-03-02 Evonik Rohm Gmbh Multiparticulate drug form and method for the preparation thereof
ITMI20012572A1 (it) * 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
KR101414810B1 (ko) * 2004-08-30 2014-07-18 주식회사 유스팜인터내셔널 국소 허혈 모델에서의 가용화 ｕｄｃａ의 신경보호 효과
ATE506955T1 (de) * 2004-10-15 2011-05-15 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
CA2585471A1 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
EP2367554A4 (en) 2008-11-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Bile acid reflux inhibitor for the treatment of obesity and diabetes
JP2012509892A (ja) 2008-11-26 2012-04-26 サティオゲン ファーマシューティカルズ，インク． サティオゲン類を含有する組成物及び使用の方法
US8470885B2 (en) 2009-01-12 2013-06-25 Biokier, Inc. Composition and method for treatment of diabetes
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
EP2480246A4 (en) 2009-09-23 2013-02-27 Biokier Inc COMPOSITION AND METHOD FOR THE TREATMENT OF DIABETES
US20110152204A1 (en) * 2009-12-18 2011-06-23 Satiogen Pharmaceuticals, Inc. Treatment of Obesity or Diabetes with Bile Acid Sequestrants
EP3593802A3 (en) 2010-05-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
KR102051031B1 (ko) 2011-10-28 2019-12-02 루메나 파마수티컬즈, 인코포레이티드 고담혈증 및 담즙 정체성 간 질환 치료용 담즙산 재순환 억제제
BR112014010223B8 (pt) 2011-10-28 2021-02-23 Lumena Pharmaceuticals Llc uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica
WO2015142178A1 (en) 2014-03-20 2015-09-24 Disphar International B.V. Bile acid composition with enhanced solubility

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
SE457958B (sv) * 1984-12-12 1989-02-13 Huhtamaeki Oy Vattenloeslig hemin-arginat eller hemin-lysinat-foerening, foerfarande foer framstaellning daerav samt anvaendning daerav foer tillverkning av medicinska kompositioner
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1212141B (it) * 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
YU183988A (en) * 1988-09-30 1990-08-31 Lek Tovarna Farmacevtskih Process for preparing dispersion pills of dihydroergotoxine

Also Published As

Publication number Publication date
JPH0597676A (ja) 1993-04-20
CA2065773C (en) 1999-01-26
KR970005176B1 (ko) 1997-04-14
JP2509045B2 (ja) 1996-06-19
US5380533A (en) 1995-01-10
ES2090395T3 (es) 1996-10-16
CA2065773A1 (en) 1992-10-13
EP0509335A1 (en) 1992-10-21
DE69212879D1 (de) 1996-09-26
KR920019359A (ko) 1992-11-19
ITBO910113A0 (it) 1991-04-12
ITBO910113A1 (it) 1992-10-12
DE69212879T2 (de) 1997-01-23
EP0509335B1 (en) 1996-08-21

Similar Documents

Publication Publication Date Title
IT1245889B (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
CA2065773A1 (en) Gastroresistant pharmaceutical formulations for oral administration containing bile acids
IT1245891B (it) Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
EP3684418B1 (en) Compounds for the treatment of cysteamine sensitive disorders
BG104620A (en) Oral pharmaceutical extended release dosage form
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
NO890194L (no) Galenisk middel.
BR9610480A (pt) Inibição do fator alfa de necrose tumoral
RU2007104095A (ru) Применение твердой пероральной дозировочной композиции пролонгированного действия для приготовления лекарственных средств
DE69805001D1 (de) Osmotische darreichungsform mit zwei mantelschichten
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
EE04238B1 (et) Asendatud 1,2,3,4-tetrahüdronaftaleeni derivaadid, meetod selle valmistamiseks, nimetatud terapeutilise toimega aineid sisaldavad ravimkoostised ja nimetatud aktiivsete ühendite kasutamine teraapias
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
EA200401369A1 (ru) Замедленно высвобождающие лекарственные композиции гвайфенезина
PT835103E (pt) Nanoparticulas para administracao oral de agentes farmaceuticos de baixa solubilidade
IT8720771A0 (it) Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
AU8013991A (en) Pharmaceutical compositions and methods for alleviating gastrointestinal symptoms induced by nonsteroidal anti-inflammatory drugs
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
EP0305968A3 (en) Compositions against protozoal diseases
RU2003105601A (ru) Лекарственный препарат, предназначенный для лечения сексуальных расстройств
NO980384L (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423